In the U.S., the ACURATE neo2 Aortic Valve System and the ACURATE Prime Aortic Valve System are investigational devices. Price Action: BSX stock is down 1.66% at $83.16 at last check Wednesday.

Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORPORATION (BSX). Of the 22 guru strategies we follow, BSX rates highest using our Multi-Factor Investor model based on the ...

Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORPORATION (BSX). Of the 22 guru strategies we follow, BSX rates highest using our Multi-Factor Investor model based on the ...

Boston Scientific Corporation (NYSE:BSX) Q3 2024 Earnings Call Transcript October 23, 2024 Boston Scientific Corporation ...

Neurology Sales Growth: 10% in Q3 2024. Endoscopy Sales Growth: 7% organically in Q3 2024. Boston Scientific Corp (NYSE:BSX) reported a 19% growth in operational sales and an 18% increase in organic ...

Endoscopy Sales Growth: 7% organically in Q3 2024. Boston Scientific Corp (NYSE:BSX) reported a 19% growth in operational sales and an 18% increase in organic sales for Q3 2024, exceeding their ...

Boston Scientific (NYSE:BSX) shares were down 5% in morning trading Wednesday following news that the company has paused a study for its new FARAPULSE Pulse Field Ablation system due to unforeseen ...

The street high price target from B of A Securities is $100.0, while the street low from Deutsche Bank is $78.0. Price Action: BSX stock is down 5.31% at $83.34 at the last check on Wednesday.

View upcoming earnings forecasts and in-depth analysis of company forecasts.

and has also served as chief business development officer at Nova Ltd in addition to spending 16 years in a variety of roles at Zurich Insurance Co Ltd. His responsibilities at the BSX include ...